Novo Nordisk Confirms That It Submitted An Unsolicited Proposal To Acquire Metsera For $56.50, Equal To An Approximate Equity Value Of $6.5B Or Enterprise Value Of $6B And Contingent Value Rights For Up To $21.25

Metsera, Inc. 0.00%
Novo Nordisk A/S Sponsored ADR Class B -0.27%

Metsera, Inc.

MTSR

70.50

0.00%

Novo Nordisk A/S Sponsored ADR Class B

NVO

47.86

-0.27%

Novo Nordisk Confirms That It Submitted An Unsolicited Proposal To Acquire Metsera For $56.50, Equal To An Approximate Equity Value Of $6.5B Or Enterprise Value Of $6B And Contingent Value Rights For Up To $21.25
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via